As revealed by a notification issued by Thai Food and Drug Adminnature’s bounty maximum calcium citrate plus vitamin distratisolgar d3 calciumon (FDA) on May 23, 2024, in orcal mag solaraydecalcitrate tabletr to make up for the supervision vacancy of alcitracal with magnesiumternative protein products, Thai FDA issued a draft named “Proposal for Developing Regulations and Regulatory Measures Governing the Supervision of Alternative Protein Products”, involving the products’ technical requirements, labeling and contaminant levels. The consultation period will end on June 7, 2024.